Can lipid-lowering medication reduce the prevalence of atrial fibrillation in patients with left ventricular dysfunction?

被引：0
|
作者：
Olshansky, Brian [1 ]
机构：
[1] Univ Iowa, Iowa City, IA 52242 USA
来源：
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2007年 / 4卷 / 01期
关键词：
atrial fibrillation; fibrates; left ventricular dysfunction; lipid-lowering drugs; statins;
D O I：
10.1038/ncpcardio0724
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [31] Blood Lipid Levels, Lipid-Lowering Medications, and the Incidence of Atrial Fibrillation The Atherosclerosis Risk in Communities Study
    Lopez, Faye L.
    Agarwal, Sunil K.
    MacLehose, Richard F.
    Soliman, Elsayed Z.
    Sharrett, A. Richey
    Huxley, Rachel R.
    Konety, Suma
    Ballantyne, Christie M.
    Alonso, Alvaro
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (01): : 155 - 162
  • [32] Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction - Insight from the studies of left ventricular dysfunction (SOLVD) trials
    Vermes, E
    Tardif, JC
    Bourassa, MG
    Racine, N
    Levesque, S
    White, M
    Guerra, PG
    Ducharme, A
    CIRCULATION, 2003, 107 (23) : 2926 - 2931
  • [33] EVALUATION OF THE PERFORMANCE OF MASEF SCORE IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) UNDER A LIPID-LOWERING MEDICATION
    Martinez-Arranz, Ibon
    Banales, Jesus
    Alonso, Cristina
    Mayo, Rebeca
    Arrese, Marco
    Crespo, Javier
    Noureddin, Mazen
    HEPATOLOGY, 2024, 80 : S619 - S620
  • [34] Can ventricular rate stabilisation reduce symptoms of atrial fibrillation?
    Dini, P
    Laurenzi, F
    CARDIAC ARRHYTHMIAS 2001, 2002, : 536 - 541
  • [35] LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AS A PREDICTOR OF THE NONVALVULAR ATRIAL FIBRILLATION
    Music, Ljilja
    Knezevic, Bozidarka
    Bulatovic, Nebojsa
    JOURNAL OF HYPERTENSION, 2016, 34 : E297 - E297
  • [36] REVERSIBILITY OF LEFT VENTRICULAR DYSFUNCTION POST ATRIAL FIBRILLATION ABLATION
    Chin, A.
    Menon, S. M. Divakara
    Nair, G. M.
    Morillo, C. A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S114 - S114
  • [37] Acute Rate Control in Atrial Fibrillation With Left Ventricular Dysfunction
    Momomura, Shin-ichi
    CIRCULATION JOURNAL, 2013, 77 (04) : 893 - 894
  • [38] Left ventricular dysfunction in atrial fibrillation and heart failure risk
    Kuo, Jen-Yuan
    Chang, Sheng-Hsiung
    Sung, Kuo-Tzu
    Chi, Po-Ching
    Liao, Jo-Nan
    Chao, Tze-Fan
    Su, Cheng-Huang
    Yeh, Hung-, I
    Hung, Chung-Lieh
    ESC HEART FAILURE, 2020, 7 (06): : 3694 - 3706
  • [39] Reversal of left ventricular dysfunction following ablation of atrial fibrillation
    Gentlesk, Philip J.
    Sauer, William H.
    Gerstenfeld, Edward P.
    Lin, David
    Dixit, Sanjay
    Zado, Erica
    Callans, Pa-C David
    Marchlinski, Francis E.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (01) : 9 - 14
  • [40] Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction
    Oka, Eiichiro
    Iwasaki, Yu-ki
    Maru, Eugene
    Fujimoto, Yuhi
    Ito-Hagiwara, Kanako
    Hayashi, Hiroshi
    Yamamoto, Teppei
    Yodogawa, Kenji
    Hayashi, Meiso
    Shimizu, Wataru
    CIRCULATION JOURNAL, 2019, 83 (04) : 793 - 800
12345